Molecules 2014, 19(4), 3851-3868; doi:10.3390/molecules19043851
Article

N-Substituted 2-Isonicotinoylhydrazinecarboxamides — New Antimycobacterial Active Molecules

1email, 1email, 2email, 1email, 2,* email, 2email, 3email and 1,* email
Received: 28 February 2014; in revised form: 21 March 2014 / Accepted: 24 March 2014 / Published: 28 March 2014
(This article belongs to the Section Medicinal Chemistry)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: This report presents a new modification of the isoniazid (INH) structure linked with different anilines via a carbonyl group obtained by two synthetic procedures and with N-substituted 5-(pyridine-4-yl)-1,3,4-oxadiazole-2-amines prepared by their cyclisation. All synthesised derivatives were characterised by IR, NMR, MS and elemental analyses and were evaluated in vitro for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv, Mycobacterium avium 330/88, Mycobacterium kansasii 235/80 and one clinical isolated strain of M. kansasii 6509/96. 2-Isonicotinoyl-N-(4-octylphenyl)hydrazinecarboxamide displayed an in vitro efficacy comparable to that of INH for M. tuberculosis with minimum inhibitory concentrations (MICs) of 1–2 μM. Among the halogenated derivatives, the best anti-tuberculosis activity was found for 2-isonicotinoyl-N-(2,4,6-trichlorophenyl)hydrazinecarboxamide (MIC = 4 μM). In silico modelling on the enoyl-acyl carrier protein reductase InhA confirmed that longer alkyl substituents are advantageous for the interactions and affinity to InhA. Most of the hydrazinecarboxamides, especially those derived from 4-alkylanilines, exhibited significant activity against INH-resistant nontuberculous mycobacteria.
Keywords: InhA inhibition; in silico docking; in vitro antimycobacterial activity; 2-isonicotinoylhydrazinecarboxamide; 5-(pyridine-4-yl)-1,3,4-oxadiazol-2-amine; tuberculosis
PDF Full-text Download PDF Full-Text [577 KB, uploaded 18 June 2014 20:38 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Rychtarčíková, Z.; Krátký, M.; Gazvoda, M.; Komlóová, M.; Polanc, S.; Kočevar, M.; Stolaříková, J.; Vinšová, J. N-Substituted 2-Isonicotinoylhydrazinecarboxamides — New Antimycobacterial Active Molecules. Molecules 2014, 19, 3851-3868.

AMA Style

Rychtarčíková Z, Krátký M, Gazvoda M, Komlóová M, Polanc S, Kočevar M, Stolaříková J, Vinšová J. N-Substituted 2-Isonicotinoylhydrazinecarboxamides — New Antimycobacterial Active Molecules. Molecules. 2014; 19(4):3851-3868.

Chicago/Turabian Style

Rychtarčíková, Zuzana; Krátký, Martin; Gazvoda, Martin; Komlóová, Markéta; Polanc, Slovenko; Kočevar, Marijan; Stolaříková, Jiřina; Vinšová, Jarmila. 2014. "N-Substituted 2-Isonicotinoylhydrazinecarboxamides — New Antimycobacterial Active Molecules." Molecules 19, no. 4: 3851-3868.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert